负载类血管生成因子3的可注射水凝胶局部控释体系构建及其对糖尿病下肢缺血病变的治疗作用

批准号:
51973125
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
纪智礼
依托单位:
学科分类:
生物医用有机高分子材料
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
纪智礼
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
糖尿病足部溃疡(糖足)是糖尿病的主要并发症之一,由高糖损伤血管内皮细胞造成糖尿病下肢动脉堵塞所致。血管生成样蛋白3(ANGPTL3)由肝分泌入血,调控血管内皮细胞附着和迁徙,促进血管生成,糖足局部治疗具有非常大的潜力,但缺乏相应的药物载体。已有研究报道,注射微泡、水凝胶等体系的载药体系可用于糖足的治疗,但是微纳米微泡注射到局部后易于流失;而水凝胶负载药物后药物释放速度往往过快,难以达到治疗效果。本研究结合微泡和水凝胶的优势,采用聚内酯微泡作为直接载体负载ANGPTL3,再通过水凝胶负载微泡后,注射到糖足成胶,保证持续释放有效浓度的ANGPTL3,达到促进血管生成的效果。同时由于聚内酯和水凝胶材料均可降解,体内无残留,具有安全性。本申请项目拟利用材料学及生物学对ANGPTL3在局部释放行为的控制及治疗效果进行评估,建立缓释体系-ANGPTL3释放-治疗效果之间的构效关系图谱。
英文摘要
Diabetic foot ulcer is one of the main complications and main cause of disability in patients with diabetes mellitus. Diabetic foot is the result of hyperglycemia-induced vascular endothelial cell injury and dysfunction which lead to artery occlusion. Angiogenesis like protein 3 is exclusively produced by hepatocytes. Upon secretion, it could bind vascular endothelial cells through integrin αvβ3 receptor and regulate cell adhesion and migration for angiogenesis. Topical administration of ANGPTL3 could be beneficial for endothelial cell protection and has great potential in the treatment of diabetic feet. However, there is a lack of suitable drug carriers for ANGPTL3. It has been reported that the drug delivery systems such as injecting microbubbles or hydrogels can be used for the treatment of diabetic feet. However, the micronano microbubbles are easy to drain after being injected into the local area and the drug release rate is often too fast after being loaded with hydrogel, both of which are the obstacles to achieve the therapeutic effect. Giving that hydrogel has great advantages in biocompatibility, hydrogel could serve as vehicle for ANGPTL3 application onto diabetic foot. By doing so, the sustained ANGPTL3 concentration could be obtained in foot ulcer to achieve desirable angiogenic effect. In the meantime, hydrogel materials are degraded along with the release of drug for safety. The aim of this project is to evaluate the regulation and therapeutic effect of ANGPTL3 in local release behavior and to establish a structure-effect relationship map between the release-treatment effect of the sustained release system and the effect of ANGPTL3.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1039/d0ra10232f
发表时间:2021-02-04
期刊:RSC advances
影响因子:3.9
作者:Shen H;Hu X
通讯作者:Hu X
DOI:--
发表时间:2022
期刊:医学综述
影响因子:--
作者:董家乐;牛烁;韩威;纪智礼
通讯作者:纪智礼
可光热转换、靶向巨噬细胞的氟基支化可降解核酸递送载体的可控构建及其在心肌梗死治疗中的应用研究
- 批准号:52373294
- 项目类别:面上项目
- 资助金额:52万元
- 批准年份:2023
- 负责人:纪智礼
- 依托单位:
基于多因素、多时点、多状态、多组学数据的心血管病发生发展预测数学模型与算法
- 批准号:12226005
- 项目类别:数学天元基金项目
- 资助金额:200.00万元
- 批准年份:2022
- 负责人:纪智礼
- 依托单位:
国内基金
海外基金
